Oliver Rolf Baumann
Director · Veraxa Biotech AG - Post de-SPAC
- 2026
- Aug 31, 2026
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Oliver Rolf Baumann files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christoph Samuel Ziegler - $33K in VRXA purchases and sales in the last 12 months
- Marc Gruninger - $10K in VRXA purchases and sales in the last 12 months
- Christoph Rudiger Antz - $8K in VRXA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Oliver Rolf Baumann?
Oliver Rolf Baumann is a corporate insider, tracked as Director of Veraxa Biotech AG - Post de-SPAC (VRXA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Oliver Rolf Baumann submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Oliver Rolf Baumann been buying or selling stock?
Recorded transactions: 1 open-market purchase ($75K) and 0 open-market sales across all tracked filings.
